<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Elsayed E</submitter><funding>NIDDK NIH HHS</funding><funding>NIDDK</funding><pagination>329-335</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10937019</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>19(3)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Intradialytic hypertension, defined as an increase in BP from pre- to post-hemodialysis (HD), affects 5%-15% of patients receiving maintenance HD and is associated with cardiovascular and all-cause mortality. Hypervolemia is believed to be a major etiological factor, yet the association of more objective biomarkers of volume status with intradialytic hypertension is not well described.&lt;h4>Methods&lt;/h4>In a post hoc analysis of the Frequent Hemodialysis Network Daily Trial ( n =234), using data from baseline, 1-, 4-, and 12-month visits ( n =800), we used random-effects regression to assess the association of bioimpedance estimates of volume (vector length) with post-HD systolic BP (continuous) and any increase in systolic BP (categorical) from pre- to post-HD. We adjusted models for randomized group; age; sex; self-reported race; Quételet (body mass) index; vascular access; HD vintage; hypertension; history of heart failure; diabetes; residual kidney function (urea clearance); pre-HD systolic BP; ultrafiltration rate; serum-dialysate sodium gradient; and baseline values of hemoglobin, phosphate, and equilibrated Kt/V urea.&lt;h4>Results&lt;/h4>The mean age of participants was 50±14 years, 39% were female, and 43% were Black. In adjusted models, shorter vector length (per 50 Ω/m) was associated with higher post-HD systolic BP (2.9 mm Hg; 95% confidence interval [CI], 1.6 to 4.3) and higher odds of intradialytic hypertension (odds ratio 1.66; 95% CI, 1.07 to 2.55). Similar patterns of association were noted with a more stringent definition of intradialytic hypertension (>10 mm Hg increase from pre- to post-HD systolic BP), where shorter vector length (per 50 Ω/m) was associated with a higher odds of intradialytic hypertension (odds ratio 2.17; 95% CI, 0.88 to 5.36).&lt;h4>Conclusions&lt;/h4>Shorter vector length, a bioimpedance-derived proxy of hypervolemia, was independently associated with higher post-HD systolic BP and risk of intradialytic hypertension.</pubmed_abstract><journal>Clinical journal of the American Society of Nephrology : CJASN</journal><pubmed_title>Association of Bioimpedance Parameters with Increases in Blood Pressure during Hemodialysis.</pubmed_title><pmcid>PMC10937019</pmcid><funding_grant_id>DK129749</funding_grant_id><funding_grant_id>R01 DK133871</funding_grant_id><funding_grant_id>R01 DK129749</funding_grant_id><funding_grant_id>K23 DK127248</funding_grant_id><pubmed_authors>Ravi KS</pubmed_authors><pubmed_authors>Elsayed E</pubmed_authors><pubmed_authors>Farag YMK</pubmed_authors><pubmed_authors>Chertow GM</pubmed_authors><pubmed_authors>Mc Causland FR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association of Bioimpedance Parameters with Increases in Blood Pressure during Hemodialysis.</name><description>&lt;h4>Background&lt;/h4>Intradialytic hypertension, defined as an increase in BP from pre- to post-hemodialysis (HD), affects 5%-15% of patients receiving maintenance HD and is associated with cardiovascular and all-cause mortality. Hypervolemia is believed to be a major etiological factor, yet the association of more objective biomarkers of volume status with intradialytic hypertension is not well described.&lt;h4>Methods&lt;/h4>In a post hoc analysis of the Frequent Hemodialysis Network Daily Trial ( n =234), using data from baseline, 1-, 4-, and 12-month visits ( n =800), we used random-effects regression to assess the association of bioimpedance estimates of volume (vector length) with post-HD systolic BP (continuous) and any increase in systolic BP (categorical) from pre- to post-HD. We adjusted models for randomized group; age; sex; self-reported race; Quételet (body mass) index; vascular access; HD vintage; hypertension; history of heart failure; diabetes; residual kidney function (urea clearance); pre-HD systolic BP; ultrafiltration rate; serum-dialysate sodium gradient; and baseline values of hemoglobin, phosphate, and equilibrated Kt/V urea.&lt;h4>Results&lt;/h4>The mean age of participants was 50±14 years, 39% were female, and 43% were Black. In adjusted models, shorter vector length (per 50 Ω/m) was associated with higher post-HD systolic BP (2.9 mm Hg; 95% confidence interval [CI], 1.6 to 4.3) and higher odds of intradialytic hypertension (odds ratio 1.66; 95% CI, 1.07 to 2.55). Similar patterns of association were noted with a more stringent definition of intradialytic hypertension (>10 mm Hg increase from pre- to post-HD systolic BP), where shorter vector length (per 50 Ω/m) was associated with a higher odds of intradialytic hypertension (odds ratio 2.17; 95% CI, 0.88 to 5.36).&lt;h4>Conclusions&lt;/h4>Shorter vector length, a bioimpedance-derived proxy of hypervolemia, was independently associated with higher post-HD systolic BP and risk of intradialytic hypertension.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-04T09:09:12.62Z</modification><creation>2025-04-04T09:09:12.62Z</creation></dates><accession>S-EPMC10937019</accession><cross_references><pubmed>37971865</pubmed><doi>10.2215/cjn.0000000000000356</doi><doi>10.2215/CJN.0000000000000356</doi></cross_references></HashMap>